Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions
In a randomised, parallel-group waitlist-controlled exploratory study (n=29) of psychedelic-naïve clergy, two supported psilocybin sessions were well tolerated and produced significant, sustained increases in religious practices, attitudes, perceived leadership effectiveness, and broader psychological wellbeing. These effects persisted up to 16 months and were frequently rated among participants' most spiritually meaningful experiences.
Authors
- Roland Griffiths
- Matthew Johnson
- Stephen Ross
Published
Abstract
Background
Although historical writings, anthropological accounts, and experimental studies document associations between psilocybin use and religion, no prospective experimental study has investigated how the effects of psilocybin are experienced and interpreted by religious clergy. This exploratory study evaluated the overall safety and the acute and enduring effects of psilocybin in clergy.
Methods
Participants were psychedelic-naïve clergy from various major world religions. A randomized, parallel group, waitlist control design was used to assess the effects of two supported psilocybin sessions, with participants receiving 20 and then 20 or 30 mg/70 kg about 1 month later. Outcomes were compared between the Immediate Group ( n = 13) and the Delayed Group ( n = 16) at 6 months after screening using self-report measures. The effects of psilocybin were also assessed on session days and 4 and 16 months after the second psilocybin session in the 24 participants who completed both sessions.
Results
The primary outcome assessment at 6 months after screening showed that, compared with the delayed control group, participants who had received psilocybin reported significantly greater positive changes in their religious practices, attitudes about their religion, and effectiveness as a religious leader, as well as in their non-religious attitudes, moods, and behavior. Follow-up assessments showed that positive changes in religious and non-religious attitudes and behavior were sustained through 16 months after the second psilocybin session. At that time, participants rated at least one of their psilocybin experiences to be among the top five most spiritually significant (96%), profoundly sacred (92%), psychologically insightful (83%), and psychologically meaningful (79%) of their lives. Furthermore, 42% rated one of their experiences to be the single most profound of their lifetime. At 16-months follow-up, most (79%) strongly endorsed that the experiences had positive effects on their religious practices (e.g., prayer or meditation) and their daily sense of the sacred, and most (71%) reported positive changes in their appreciation of religious traditions other than their own. Although no serious adverse events were reported, 46% rated a psilocybin experience as among the top five most psychologically challenging of their lives.
Conclusions
In this population of clergy, psilocybin administration was safe and increased multiple domains of overall psychological well-being including positive changes in religious attitudes and behavior as well as their vocation as a religious leader. The study was limited by a waitlist control design, homogenous sample, and the use of some unvalidated outcome measures. Further research with more rigorous control conditions and diverse samples is needed.
Research Summary of 'Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions'
Blossom's Take
Much of the academic psychedelic research can be traced back to the Good Friday experiment. This study, led by the late Roland Griffiths, applies the rigour of today to the study of psychedelics in religious leaders. They once again find significant (and sustained) spiritual and wellbeing changes.
Introduction
Psychedelic compounds such as psilocybin can occasion subjective states often described with religious or spiritual language, including experiences of unity, a felt sense of revelation (noetic quality), transcendence of time and space, intense positive mood, and ineffability. Previous prospective studies and survey research have linked psilocybin-occasioned mystical experiences with sustained improvements in wellbeing, meaning, and spiritual significance, and historical and anthropological records document sacramental uses of psychedelics in some Indigenous and religious traditions. Despite this background, little experimental work has examined how professionally trained clergy—individuals formally educated in theology and engaged in religious leadership within major world religions—experience and interpret psilocybin sessions. Griffiths and colleagues designed an exploratory, randomised, parallel-group waitlist study to evaluate the acute safety and both short- and long-term effects of two supported psilocybin sessions in psychedelic-naïve clergy from several major world religions. The study aimed to characterise persisting changes in psychological functioning, spiritual attitudes and practices, well-being, and vocational effects attributed to psilocybin, with a pre-registered Interim Questionnaire administered 6 months after enrolment to compare those who received psilocybin immediately with a delayed (waitlist) control group. The investigators hypothesised that, following the intervention, clergy would report increases in wellbeing, life satisfaction, spiritual practices, and positive changes in attitudes and behaviours relevant to their religious vocation.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typeindividual
- Journal
- Compound
- Topics
- Authors
- APA Citation
Griffiths, R. R., Jesse, R., Richards, W. A., Johnson, M. W., Sepeda, N. D., Bossis, A. P., & Ross, S. (2025). Effects of psilocybin on religious and spiritual attitudes and behaviors in clergy from various major world religions. Psychedelic Medicine, 3(4), 172-191.
References (21)
Papers cited by this study that are also in Blossom
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Slevc, L. R., Barrett, F. S., Robbins, H. et al. · Frontiers in Psychology (2017)
Yaden, D. B., Le Nguyen, K. D., Kern, M. L. et al. · Journal of Humanistic Psychology (2016)
Swee, M. B., Nayak, S., Hurwitz, E. et al. · PLOS ONE (2022)
MacLean, K. A., Leoutsakos, J. S., Johnson, M. W. et al. · Journal for the Scientific Study of Religion (2012)
Griffiths, R. R., Hurwitz, E. S., Davis, A. K. et al. · PLOS ONE (2019)
Nayak, S., Singh, M., Yaden, D. B. et al. · Journal of Psychopharmacology (2022)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Journal of Psychopharmacology (2017)
Show all 21 referencesShow fewer
Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Garcia-Romeu, A., Griffiths, R. R., Johnson, M. W. · Current Drug Abuse Reviews (2015)
Winkelman, M. J. · Current Drug Abuse Reviews (2014)
Halpern, J. H., Sherwood, A. R., Hudson, J. I. et al. · Biological Psychiatry (2005)
Bouso, J. C., Andión, O., Sarris, J. et al. · PLOS Global Public Health (2022)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Barrett, F. S., Bradstreet, M. P., Leoutsakos, J. M. S. et al. · Journal of Psychopharmacology (2016)
Roseman, L., Ron, Y., Saca, A. et al. · Frontiers in Pharmacology (2021)
Peacock, C., Mascaro, J. S., Brauer, E. et al. · PLOS ONE (2024)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.